Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
暂无分享,去创建一个
[1] J. Reichert. Global antibody development trends , 2009, mAbs.
[2] Vladimir I Razinkov,et al. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies. , 2012, Journal of pharmaceutical sciences.
[3] Marcello Coreno,et al. Electronic structure of aromatic amino acids studied by soft x-ray spectroscopy. , 2009, The Journal of chemical physics.
[4] E. Blout,et al. Circular dichroism spectroscopy of bovine pancreatic trypsin inhibitor and five altered conformational states. Relationship of conformation and the refolding pathway of the trypsin inhibitor. , 1981, Biochemistry.
[5] W. Friess,et al. Influence of pH and ionic strength on IgG adsorption to vials. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] O. Ptitsyn,et al. α‐lactalbumin: compact state with fluctuating tertiary structure? , 1981, FEBS letters.
[7] Linda O Narhi,et al. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations. , 2011, Journal of pharmaceutical sciences.
[8] N. Greenfield. Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.
[9] S. Shimizu,et al. Preferential hydration and the exclusion of cosolvents from protein surfaces. , 2004, The Journal of chemical physics.
[10] H. Gadgil,et al. Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc , 2011, The Journal of Biological Chemistry.
[11] J L Cleland,et al. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. , 2001, Journal of pharmaceutical sciences.
[12] B. Wallace,et al. Circular dichroism analyses of membrane proteins: an examination of differential light scattering and absorption flattening effects in large membrane vesicles and membrane sheets. , 1984, Analytical biochemistry.
[13] H. Bose,et al. Mitochondrial 3β-Hydroxysteroid Dehydrogenase Enzyme Activity Requires Reversible pH-dependent Conformational Change at the Intermembrane Space* , 2012, The Journal of Biological Chemistry.
[14] Hanns-Christian Mahler,et al. Forced degradation of therapeutic proteins. , 2012, Journal of pharmaceutical sciences.
[15] Theodore W Randolph,et al. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin. , 2010, Journal of pharmaceutical sciences.
[16] D. Ejima,et al. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies , 2006, Proteins.
[17] M C Manning,et al. Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. , 1999, Biochemistry.
[18] G. Makhatadze,et al. Electrostatic Contribution of Surface Charge Residues to the Stability of a Thermophilic Protein: Benchmarking Experimental and Predicted pKa Values , 2012, PloS one.
[19] P. Dalby,et al. The solution structure of rabbit IgG accounts for its interactions with the Fc receptor and complement C1q and its conformational stability. , 2013, Journal of molecular biology.
[20] Sandeep Yadav,et al. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. , 2010, Journal of pharmaceutical sciences.
[21] M. Pikal,et al. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody. , 2007, Journal of pharmaceutical sciences.
[22] P. Lerch,et al. L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions. , 2010, Biologicals : journal of the International Association of Biological Standardization.
[23] P. Závodszky,et al. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution. , 2006, Biologicals : journal of the International Association of Biological Standardization.
[24] Satoshi Ohtake,et al. Interactions of formulation excipients with proteins in solution and in the dried state. , 2011, Advanced drug delivery reviews.
[25] L. Gierasch,et al. Effects of osmolytes on protein folding and aggregation in cells. , 2007, Methods in enzymology.
[26] A. Drake,et al. Simultaneous determination of photometric accuracy during circular dichroism measurements , 2010 .
[27] Huub Schellekens,et al. Bioequivalence and the immunogenicity of biopharmaceuticals , 2002, Nature Reviews Drug Discovery.
[28] Wei Wang,et al. Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.
[29] Santosh V. Thakkar,et al. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies , 2013, Protein science : a publication of the Protein Society.